WO2021081237A1
|
|
Mesh chopping of neural progenitor cell aggregates
|
WO2021081229A1
|
|
Cortical neural progenitor cells from ipscs
|
WO2021076399A1
|
|
Internal ultraviolet therapy
|
WO2021062272A2
|
|
Analysis methods for multiplex tissue imaging including imaging mass cytometry data
|
WO2021050765A1
|
|
Systems and methods of deep learning for large-scale dynamic magnetic resonance image reconstruction
|
WO2021046361A1
|
|
Use of calcineurin inhibitor free ctla4-ig + anti-il6/il6r for long term immunosuppression in solid organ transplant recipients
|
WO2021050214A1
|
|
Apparatus and method for forming a custom cement-on-cement articulating hip spacer
|
US2021106844A1
|
|
Internal ultraviolet therapy
|
WO2021026522A2
|
|
Method of generating activated t cells for cancer therapy
|
WO2021026507A1
|
|
Methods of improving organ function
|
WO2021011559A1
|
|
Oxygenating bite block
|
US2020408766A1
|
|
Palmitoyl Protein Biomarkers in Purified Extracellular Vesicles for Early Identification of Clinically Significant Prostate Cancer
|
WO2020257205A1
|
|
SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
|
US2020284804A1
|
|
Methods for Detecting Post-Infectious Irritable Bowel Syndrome
|
WO2020227489A1
|
|
Therapeutically active cells and exosomes
|
US2020342958A1
|
|
Methods and systems for assessing inflammatory disease with deep learning
|
US2020318162A1
|
|
Gut bacteria in patients with inflammatory bowel disease and methods therewith in detecting ileal fibrosis
|
WO2020191076A1
|
|
Compositions and methods to treat gastrointestinal diseases and disorders
|
US2020206304A1
|
|
Methods and compositions for efficient delivery through multiple bio barriers
|
WO2020185672A1
|
|
Anti-cd38 agents for desensitization and treatment of antibody-mediated rejection of organ transplants
|